╌>

'Young blood' company Ambrosia halts patient treatments after FDA warning

  

Category:  Health, Science & Technology

Via:  perrie-halpern  •  5 years ago  •  11 comments

 'Young blood' company Ambrosia halts patient treatments after FDA warning
The FDA warned consumers against infusions of plasma from young donors, saying there is no evidence that they slow aging or memory loss, and can be dangerous.

S E E D E D   C O N T E N T



By   Shamard Charles, M.D.

A   company   that charged patients thousands of dollars for infusions of blood plasma from younger donors said Tuesday that it had stopped treating patients after the Food and Drug Administration warned consumers against such treatments, purported to prevent aging and memory loss.

The company, Ambrosia, said on its website that it had “ceased patient treatments.” The announcement came hours after the FDA issued a   statement   saying there is no proof that plasma from young donors can be used as a treatment for dementia, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease or post-traumatic stress disorder, as some companies have claimed.

The plasma infusions can also be dangerous, the agency added, because they are associated with infectious, allergic, respiratory and cardiovascular risks.

“We’re alerting consumers and health care providers that treatments using plasma from young donors have not gone through the rigorous testing that the FDA normally requires in order to confirm the therapeutic benefit of a product and to ensure its safety,” Dr. Scott Gottlieb, food and drug commissioner, and Dr. Peter Marks, director of the agency’s Center for Biologics Evaluation and Research, said in a statement.

The federal agency noted that several businesses offer infusions of plasma costing thousands of dollars per infusion for a variety of conditions. Such companies can often avoid FDA drug approval processes because plasma transfusions are a well-established procedure. Ambrosia, for example, had been charging $8,000 for one liter of blood and $12,000 for two as part of a clinical trial. The blood was donated by 16- to 25-year-olds to consumers ages 35 and older.

Ambrosia’s founder, Jesse Karmazin, 34, a Stanford Medical School graduate, launched the startup three years ago. In 2017, he began a clinical trial and touted impressive results, claiming that young plasma could prevent Alzheimer’s and lower blood cholesterol. But he never made the results of his study public.

Ambrosia isn’t the only company that aggressively marketed scientifically dubious potions to those desperate to preserve their youth.

Other medical establishments, such as the Maharaj Institute in Florida, have started expensive clinical trials and openly discussed plans to charge patients for transfusions of plasma from young donors. In fact, people considering enrolling said they had been told they would have to pay $285,000,   STAT   reported last March.

“Though the use of young plasma is promising and hopeful, there needs to be rigorous trials to ensure therapeutic benefits and safety standards for each indication of use,” said Dr. Sharon Sha, a neurologist at the Stanford Neuroscience Health Center in Palo Alto, California. “I also have concerns about 'for pay' sites that encourage participation by patients who not aware of the risks and can be desperate for a cure.”

Plasma is the liquid part of blood that contains clotting factors, antibodies and other important proteins. Plasma infusions from young donors have been shown to have mildly positive results in Alzheimer's patients, according to a   small Stanford University study .

Plasma transfusions are normally given to correct for blood-clotting deficiencies in patients who are bleeding. Plasma is not FDA-approved to treat other conditions, such as normal aging or memory loss.

“The administration of plasma for indications other than those recognized or approved by the FDA should be performed by a qualified investigator or sponsor who has an active investigational new drug application with the FDA,” the FDA said


Tags

jrDiscussion - desc
[]
 
Perrie Halpern R.A.
Professor Expert
1  seeder  Perrie Halpern R.A.    5 years ago

FFP is made up from many donors and disease like Hepititus can be gotten from it. It is utterly shocking to me that people were using it for voodoo medicine. 

 
 
 
sandy-2021492
Professor Expert
1.1  sandy-2021492  replied to  Perrie Halpern R.A. @1    5 years ago

I guess very little in the way of "woo" medicine shocks me anymore.  I am frustrated that we have so many people who are so gullible as to provide them with a market.

 
 
 
Perrie Halpern R.A.
Professor Expert
1.1.1  seeder  Perrie Halpern R.A.  replied to  sandy-2021492 @1.1    5 years ago

I totally agree. This is like modern day snake oil. 

 
 
 
Enoch
Masters Quiet
1.2  Enoch  replied to  Perrie Halpern R.A. @1    5 years ago

Dear Friend Perrie Halperin:

Science. Good.

Voodoo medicine. Not good. Only peddled by those without a conscience.

Hard enough to get things right using protocols and procedures which stand the test of time. 

"Snake Oil, Anyone"?

Enoch.

 
 
 
Perrie Halpern R.A.
Professor Expert
1.2.1  seeder  Perrie Halpern R.A.  replied to  Enoch @1.2    5 years ago

Enoch,

LOL, great minds! 

"Snake Oil, Anyone"?

Read my comment above. I wrote that before I saw this

 
 
 
Enoch
Masters Quiet
1.2.2  Enoch  replied to  Perrie Halpern R.A. @1.2.1    5 years ago

Dear Friend Perrie: GMTA.

(Great Minds Think Alike).

E.

 
 
 
lady in black
Professor Quiet
3  lady in black    5 years ago

Modern day Countess of Bathory theory......

 
 
 
Perrie Halpern R.A.
Professor Expert
3.1  seeder  Perrie Halpern R.A.  replied to  lady in black @3    5 years ago
Modern day Countess of Bathory theory......

Never heard of that, so I had to google. LOL! And ewwwwwwww. 

 
 
 
sandy-2021492
Professor Expert
3.1.1  sandy-2021492  replied to  Perrie Halpern R.A. @3.1    5 years ago

I've read a couple of articles and book chapters about her.  Some say her bloodthirstiness was exaggerated, but pretty much all seem to agree that she was bloodthirsty. 

As she was nobility, it was damn near impossible to prosecute her.

 
 

Who is online















367 visitors